Optimizing the Formulation and Lyophilization Process for a Fragment Antigen Binding (Fab) Protein Using Solid-State

Lokesh Kumar1, Karthik Balakrishna Chandrababu2, Shenbaga Moorthy Balakrishnan2

  • 1Pharmaceutical Development, Genentech Inc. , San Francisco , California 94080 , United States.

Molecular Pharmaceutics
|October 1, 2019
PubMed

Related Concept Videos